Ethylene Oxide Emissions Investigation

Posted on

Migliaccio & Rathod LLP is currently investigating chemical plants across the United States that emit ethylene oxide into the air, despite the known public health risks of doing so. Ethylene oxide is commonly used as a sterilizing agent for medical equipment, and as an intermediate in chemical manufacturing. Although long considered hazardous, the Environmental Protection […]

Product Defect

Valsartan Carcinogenic Contaminants Investigation

Posted on

Migliaccio & Rathod LLP has filed a class action lawsuit against certain manufacturers of Valsartan, an angiotensin II receptor blocker used to treat high blood pressure and heart failure. The Food and Drug Administration issued a recall of Valsartan because it contained significant levels of N-nitrosodimethylamine (NDMA)—a probable human carcinogen—the long-term exposure of which increases […]